Pub Date : 2025-05-23eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1586465
Hammam A Alotaibi, Firas Madani, Rawan N Althaqib, Hamad M AlSulaiman
Orbital schwannomas are benign tumors that arise from Schwann cells in the peripheral nerves in the orbit. They typically present after the second decade of life given their slow growth and rarely before then. Diagnosis is based on clinical course and specific imaging modalities; however, the definitive diagnosis is by lesion biopsy. Surgical removal is typically curative. Herein we present the case of an 8-year-old boy with proptosis and diplopia where he exhibited the clinical findings of an orbital mass, however, the characteristic picture of orbital schwannoma was observed on imaging yet found within the inferior rectus muscle, a rare finding indeed.
{"title":"Intramuscular orbital schwannoma: case report and review of the literature.","authors":"Hammam A Alotaibi, Firas Madani, Rawan N Althaqib, Hamad M AlSulaiman","doi":"10.3389/fopht.2025.1586465","DOIUrl":"10.3389/fopht.2025.1586465","url":null,"abstract":"<p><p>Orbital schwannomas are benign tumors that arise from Schwann cells in the peripheral nerves in the orbit. They typically present after the second decade of life given their slow growth and rarely before then. Diagnosis is based on clinical course and specific imaging modalities; however, the definitive diagnosis is by lesion biopsy. Surgical removal is typically curative. Herein we present the case of an 8-year-old boy with proptosis and diplopia where he exhibited the clinical findings of an orbital mass, however, the characteristic picture of orbital schwannoma was observed on imaging yet found within the inferior rectus muscle, a rare finding indeed.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1586465"},"PeriodicalIF":0.9,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12140979/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144251167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-22eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1589771
Molly Shott, Diane Wang, John Nguyen
Periorbital necrotizing fasciitis (NF) is a rare, vision-threatening soft tissue infection that requires rapid antimicrobial treatments to minimize devastating soft tissue destruction, and debridement of affected tissue results in extensive defects requiring various techniques of reconstruction. We herein describe a case of a 58-year-old male with periorbital NF who underwent eyelid repair with intact fish skin grafts. To our knowledge, this is the first case report of fish skin grafts being used in eyelid wound management after periorbital NF.
{"title":"Case Report: Eyelid reconstruction using intact fish skin xenograft following periorbital necrotizing fasciitis.","authors":"Molly Shott, Diane Wang, John Nguyen","doi":"10.3389/fopht.2025.1589771","DOIUrl":"10.3389/fopht.2025.1589771","url":null,"abstract":"<p><p>Periorbital necrotizing fasciitis (NF) is a rare, vision-threatening soft tissue infection that requires rapid antimicrobial treatments to minimize devastating soft tissue destruction, and debridement of affected tissue results in extensive defects requiring various techniques of reconstruction. We herein describe a case of a 58-year-old male with periorbital NF who underwent eyelid repair with intact fish skin grafts. To our knowledge, this is the first case report of fish skin grafts being used in eyelid wound management after periorbital NF.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1589771"},"PeriodicalIF":0.0,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12137103/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-22eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1528766
Davide Allegrini, Raffaele Raimondi, Giovanni Montesano, Marco Caruso, Giovanna Lionetti, Adriano Carnevali, Tania Sorrentino, Vincenzo Scorcia, Mario R Romano
Purpose: The aim of this work was to track tangential traction of idiopathic epiretinal membrane from an initial assessment to the immediate post-operative phase using an enhanced version of the relaxation index (RI).
Methods: A retrospective analysis was conducted on 9 patients who underwent peeling surgery for idiopathic, symptomatic, and progressive epiretinal membrane. The RI assesses the displacement of vascular crossings in time from a fixed point, which is the retinal pigmented epithelium. This updated iteration integrates infrared images paired with OCT scans instead of OCTA.
Results: The study encompassed three timepoints: T1 (initial appointment), T2 (1 week pre-surgery), and Post (1 month post-surgery). T1 was 12± 9 months prior to surgery. A statistically significant difference (p<0.001) in RI was observed across all three timepoints; however, there was no significant correlation between RI and visual acuity (p>0.05).
Conclusion: The RI emerges as a comprehensive and direct parameter for objectively assessing and monitoring tangential traction in three dimensions across an extensive area of the posterior pole. Further streamlining of the process is necessary to integrate this feature into clinical practice effectively.
{"title":"Quantitative analysis of idiopathic epiretinal membrane traction: an updated version of the relaxation index.","authors":"Davide Allegrini, Raffaele Raimondi, Giovanni Montesano, Marco Caruso, Giovanna Lionetti, Adriano Carnevali, Tania Sorrentino, Vincenzo Scorcia, Mario R Romano","doi":"10.3389/fopht.2025.1528766","DOIUrl":"10.3389/fopht.2025.1528766","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this work was to track tangential traction of idiopathic epiretinal membrane from an initial assessment to the immediate post-operative phase using an enhanced version of the relaxation index (RI).</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 9 patients who underwent peeling surgery for idiopathic, symptomatic, and progressive epiretinal membrane. The RI assesses the displacement of vascular crossings in time from a fixed point, which is the retinal pigmented epithelium. This updated iteration integrates infrared images paired with OCT scans instead of OCTA.</p><p><strong>Results: </strong>The study encompassed three timepoints: T1 (initial appointment), T2 (1 week pre-surgery), and Post (1 month post-surgery). T1 was 12± 9 months prior to surgery. A statistically significant difference (p<0.001) in RI was observed across all three timepoints; however, there was no significant correlation between RI and visual acuity (p>0.05).</p><p><strong>Conclusion: </strong>The RI emerges as a comprehensive and direct parameter for objectively assessing and monitoring tangential traction in three dimensions across an extensive area of the posterior pole. Further streamlining of the process is necessary to integrate this feature into clinical practice effectively.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1528766"},"PeriodicalIF":0.0,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12137094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-22eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1576929
Gabriel Kabarriti, Ali Elsayed, Giannis A Moustafa, Nickisa Hodgson
Purpose: The purpose of this study is to characterize orbital inflammatory disease (OID) in a primarily Black patient population, examining their demographics, presentations, workup, treatment, and outcome.
Methods: A retrospective study was performed from January 2005 to June 2022 at two academic institutions in Brooklyn, NY. Patients included met criteria for one of the following OID conditions: non-specific orbital inflammation; nonbacterial dacryoadenitis; Tolosa-Hunt; orbital myositis; definite, possible, or probable IgG4-related ophthalmic disease; and sclerosing orbital inflammation. Data reviewed included orbital inflammatory labs, imaging, pathology, and treatment. Treatment was considered successful if a patient had complete resolution of symptoms.
Results: Thirty-nine patients met criteria for this study. 35.9% were diagnosed with dacryoadenitis, 28.2% with NSOI, 12.8% with myositis, 5.1% with possible IgG-ROD, 7.7% with probable IgG4-ROD, 7.7% with Tolosa Hunt, and 2.6% with sclerosing OI. 91% were started on steroids; 12.8% required transition to steroid-sparing therapy. 85% had a successful outcome with a resolution of symptoms.
Conclusions: This study characterizes OID in a Black patient population and compares it to prior studies done on OID. Research on underrepresented patient populations is needed to understand differences in disease presentation and improve patient outcomes.
{"title":"Orbital inflammatory disease in a primarily black patient population.","authors":"Gabriel Kabarriti, Ali Elsayed, Giannis A Moustafa, Nickisa Hodgson","doi":"10.3389/fopht.2025.1576929","DOIUrl":"10.3389/fopht.2025.1576929","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study is to characterize orbital inflammatory disease (OID) in a primarily Black patient population, examining their demographics, presentations, workup, treatment, and outcome.</p><p><strong>Methods: </strong>A retrospective study was performed from January 2005 to June 2022 at two academic institutions in Brooklyn, NY. Patients included met criteria for one of the following OID conditions: non-specific orbital inflammation; nonbacterial dacryoadenitis; Tolosa-Hunt; orbital myositis; definite, possible, or probable IgG4-related ophthalmic disease; and sclerosing orbital inflammation. Data reviewed included orbital inflammatory labs, imaging, pathology, and treatment. Treatment was considered successful if a patient had complete resolution of symptoms.</p><p><strong>Results: </strong>Thirty-nine patients met criteria for this study. 35.9% were diagnosed with dacryoadenitis, 28.2% with NSOI, 12.8% with myositis, 5.1% with possible IgG-ROD, 7.7% with probable IgG4-ROD, 7.7% with Tolosa Hunt, and 2.6% with sclerosing OI. 91% were started on steroids; 12.8% required transition to steroid-sparing therapy. 85% had a successful outcome with a resolution of symptoms.</p><p><strong>Conclusions: </strong>This study characterizes OID in a Black patient population and compares it to prior studies done on OID. Research on underrepresented patient populations is needed to understand differences in disease presentation and improve patient outcomes.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1576929"},"PeriodicalIF":0.0,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12137059/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-20eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1554279
Durgul Acan, Beyza Betul Cakar, Eyyup Karahan
Purpose: This study aimed to compare the anterior chamber depth (ACD), anterior chamber volume (ACV), and iridocorneal angle (ICA) of the eyes of patients with non-arteritic anterior ischemic optic neuropathy (NAION) and normal eyes.
Methods: In this cross-sectional study, 28 patients with NAION who were admitted to our institution were examined. Central corneal thickness (CCT), ACV, ACD, and ICA of all eyes were measured using corneal topography (Sirius, CSO, Italy). Axial lengths (ALs) were measured using an IOL-Master 500 (Carl Zeiss, Meditec). The eyes of these patients were compared with the eyes of 29 healthy individuals of similar age and gender.
Results: The mean ALs of the eyes with NAION and those in the control group were not statistically different, measuring 22.95 ± 0.68 mm and 23.13 ± 0.80mm, respectively (p=0.651). While the average ACV was 137.93 ± 41.01 mm3 in the control group, it was significantly lower at 117.86 ± 22.23 mm3 in the patients with NAION (p=0.038). The mean ACD, ICA, and CCT values in the control and study groups were not statistically different, with 2.82 ± 0.57 mm and 2.64 ± 0.31 mm, 41.62 ± 6.99° and 40.14 ± 7.04°, and 542.48 ± 19.39µm and 544.68 ± 31.26 µm, respectively (p1 = 0.236, p2 = 0.693, and p3 = 0.959). No statistical differences were found between the eyes with NAION and their fellow eyes in terms of AL, CCT, ACD, ACV, and ICA (p>0.05).
Conclusion: Differences in anterior segment morphology were observed in eyes with NAION compared to healthy eyes. Decreased ACV may be a risk factor for NAION.
{"title":"Low anterior chamber volume as a risk factor in non-arteritic anterior ischemic optic neuropathy.","authors":"Durgul Acan, Beyza Betul Cakar, Eyyup Karahan","doi":"10.3389/fopht.2025.1554279","DOIUrl":"10.3389/fopht.2025.1554279","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to compare the anterior chamber depth (ACD), anterior chamber volume (ACV), and iridocorneal angle (ICA) of the eyes of patients with non-arteritic anterior ischemic optic neuropathy (NAION) and normal eyes.</p><p><strong>Methods: </strong>In this cross-sectional study, 28 patients with NAION who were admitted to our institution were examined. Central corneal thickness (CCT), ACV, ACD, and ICA of all eyes were measured using corneal topography (Sirius, CSO, Italy). Axial lengths (ALs) were measured using an IOL-Master 500 (Carl Zeiss, Meditec). The eyes of these patients were compared with the eyes of 29 healthy individuals of similar age and gender.</p><p><strong>Results: </strong>The mean ALs of the eyes with NAION and those in the control group were not statistically different, measuring 22.95 ± 0.68 mm and 23.13 ± 0.80mm, respectively (p=0.651). While the average ACV was 137.93 ± 41.01 mm<sup>3</sup> in the control group, it was significantly lower at 117.86 ± 22.23 mm<sup>3</sup> in the patients with NAION (p=0.038). The mean ACD, ICA, and CCT values in the control and study groups were not statistically different, with 2.82 ± 0.57 mm and 2.64 ± 0.31 mm, 41.62 ± 6.99° and 40.14 ± 7.04°, and 542.48 ± 19.39µm and 544.68 ± 31.26 µm, respectively (p1 = 0.236, p2 = 0.693, and p3 = 0.959). No statistical differences were found between the eyes with NAION and their fellow eyes in terms of AL, CCT, ACD, ACV, and ICA (p>0.05).</p><p><strong>Conclusion: </strong>Differences in anterior segment morphology were observed in eyes with NAION compared to healthy eyes. Decreased ACV may be a risk factor for NAION.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1554279"},"PeriodicalIF":0.0,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12129766/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144217802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-19eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1581212
Dalia Camacho-García-Formentí, Gabriela Baylón-Vázquez, Karen Arriozola-Rodríguez, Enrique Avalos-Ramirez, Curt Hartleben-Matkin, Hugo Valdez-Flores, Damaris Hodelin-Fuentes, Alejandro Noriega
Introduction: Artificial intelligence (AI) shows promise in ophthalmology, but its potential in tertiary care settings in Latin America remains understudied. We present a Mexican AI-powered screening tool and evaluate it against first-year ophthalmology residents in a tertiary care setting in Mexico City.
Methods: We analyzed data from 435 adult patients undergoing their first ophthalmic evaluation using an AI-based platform and first-year ophthalmology residents. The platform employs an Inception V3-based multi-output classification model with 512 × 512 input resolution to capture small lesions when detecting retinal disease. To evaluate glaucoma suspects, the system uses U-Net models that segment the optic disc and cup to calculate cup-to-disc ratio (CDR) from their vertical heights. The AI and resident evaluations were compared with expert annotations for retinal disease, CDR measurements, and glaucoma suspect classification. In addition, we evaluated a synergistic approach combining AI and resident assessments.
Results: For glaucoma suspect classification, AI outperformed residents in accuracy (88.6% vs. 82.9%, p = 0.016), sensitivity (63.0% vs. 50.0%, p = 0.116), and specificity (94.5% vs. 90.5%, p = 0.062). The synergistic approach achieved a higher sensitivity (80.4%) than ophthalmic residents alone or AI alone (p < 0.001). AI's CDR estimates showed lower mean absolute error (0.056 vs. 0.105, p < 0.001) and higher correlation with expert measurements (r = 0.728 vs. r = 0.538). In the retinal disease assessment, AI demonstrated higher sensitivity (90.1% vs. 63.0% for medium/high risk, p < 0.001) and specificity (95.8% vs. 90.4%, p < 0.001). Furthermore, differences between AI and residents were statistically significant across all metrics. The synergistic approach achieved the highest sensitivity for retinal disease (92.6% for medium/high risk, 100% for high risk).
Discussion: AI outperformed first-year residents in key ophthalmic assessments. The synergistic use of AI and resident assessments showed potential for optimizing diagnostic accuracy, highlighting the value of AI as a supportive tool in ophthalmic practice, especially for early career clinicians.
导言:人工智能(AI)在眼科领域显示出前景,但其在拉丁美洲三级保健机构中的潜力仍未得到充分研究。我们介绍了一种墨西哥人工智能筛查工具,并对墨西哥城三级医疗机构的一年级眼科住院医生进行了评估。方法:我们分析了使用人工智能平台进行首次眼科评估的435名成年患者和第一年眼科住院医师的数据。该平台采用基于Inception v3的多输出分类模型,输入分辨率为512 × 512,在检测视网膜疾病时捕获小病变。为了评估青光眼的可能性,该系统使用U-Net模型,将视盘和视杯分割,从它们的垂直高度计算杯盘比(CDR)。将人工智能和住院医师评估与专家对视网膜疾病、CDR测量和青光眼可疑分类的注释进行比较。此外,我们评估了结合人工智能和居民评估的协同方法。结果:人工智能对青光眼可疑分类的准确率(88.6%比82.9%,p = 0.016)、灵敏度(63.0%比50.0%,p = 0.116)和特异性(94.5%比90.5%,p = 0.062)均优于住院医师。协同方法的灵敏度(80.4%)高于眼科住院医师单独或人工智能单独(p < 0.001)。AI的CDR估计显示出较低的平均绝对误差(0.056 vs. 0.105, p 0.001),与专家测量值的相关性较高(r = 0.728 vs. r = 0.538)。在视网膜疾病评估中,人工智能显示出更高的灵敏度(90.1%对63.0%,p 0.001)和特异性(95.8%对90.4%,p 0.001)。此外,人工智能和居民之间的差异在所有指标上都具有统计学意义。协同方法对视网膜疾病的敏感性最高(中高风险为92.6%,高风险为100%)。讨论:AI在关键眼科评估中优于第一年住院医师。人工智能和住院医师评估的协同使用显示出优化诊断准确性的潜力,突出了人工智能作为眼科实践支持工具的价值,特别是对早期职业临床医生。
{"title":"Synergistic AI-resident approach achieves superior diagnostic accuracy in tertiary ophthalmic care for glaucoma and retinal disease.","authors":"Dalia Camacho-García-Formentí, Gabriela Baylón-Vázquez, Karen Arriozola-Rodríguez, Enrique Avalos-Ramirez, Curt Hartleben-Matkin, Hugo Valdez-Flores, Damaris Hodelin-Fuentes, Alejandro Noriega","doi":"10.3389/fopht.2025.1581212","DOIUrl":"10.3389/fopht.2025.1581212","url":null,"abstract":"<p><strong>Introduction: </strong>Artificial intelligence (AI) shows promise in ophthalmology, but its potential in tertiary care settings in Latin America remains understudied. We present a Mexican AI-powered screening tool and evaluate it against first-year ophthalmology residents in a tertiary care setting in Mexico City.</p><p><strong>Methods: </strong>We analyzed data from 435 adult patients undergoing their first ophthalmic evaluation using an AI-based platform and first-year ophthalmology residents. The platform employs an Inception V3-based multi-output classification model with 512 × 512 input resolution to capture small lesions when detecting retinal disease. To evaluate glaucoma suspects, the system uses U-Net models that segment the optic disc and cup to calculate cup-to-disc ratio (CDR) from their vertical heights. The AI and resident evaluations were compared with expert annotations for retinal disease, CDR measurements, and glaucoma suspect classification. In addition, we evaluated a synergistic approach combining AI and resident assessments.</p><p><strong>Results: </strong>For glaucoma suspect classification, AI outperformed residents in accuracy (88.6% vs. 82.9%, <i>p</i> = 0.016), sensitivity (63.0% vs. 50.0%, <i>p</i> = 0.116), and specificity (94.5% vs. 90.5%, <i>p</i> = 0.062). The synergistic approach achieved a higher sensitivity (80.4%) than ophthalmic residents alone or AI alone (<i>p <</i> 0.001). AI's CDR estimates showed lower mean absolute error (0.056 vs. 0.105, <i>p <</i> 0.001) and higher correlation with expert measurements (<i>r</i> = 0.728 vs. <i>r</i> = 0.538). In the retinal disease assessment, AI demonstrated higher sensitivity (90.1% vs. 63.0% for medium/high risk, <i>p <</i> 0.001) and specificity (95.8% vs. 90.4%, <i>p <</i> 0.001). Furthermore, differences between AI and residents were statistically significant across all metrics. The synergistic approach achieved the highest sensitivity for retinal disease (92.6% for medium/high risk, 100% for high risk).</p><p><strong>Discussion: </strong>AI outperformed first-year residents in key ophthalmic assessments. The synergistic use of AI and resident assessments showed potential for optimizing diagnostic accuracy, highlighting the value of AI as a supportive tool in ophthalmic practice, especially for early career clinicians.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1581212"},"PeriodicalIF":0.9,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12127187/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144210406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-15eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1583599
Sujit Shah, Gautam Motwani, Pavan K Verkicharla
{"title":"\"REACH'' for troubleshooting peripheral defocus myopia control spectacles.","authors":"Sujit Shah, Gautam Motwani, Pavan K Verkicharla","doi":"10.3389/fopht.2025.1583599","DOIUrl":"10.3389/fopht.2025.1583599","url":null,"abstract":"","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1583599"},"PeriodicalIF":0.0,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12119269/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144183685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-09eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1616466
Catherine Cheng, Barbara Pierscionek
{"title":"Editorial: Women in lens and cataract.","authors":"Catherine Cheng, Barbara Pierscionek","doi":"10.3389/fopht.2025.1616466","DOIUrl":"https://doi.org/10.3389/fopht.2025.1616466","url":null,"abstract":"","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1616466"},"PeriodicalIF":0.0,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12098023/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144144723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-05eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1493171
Stefano Malvindi, Elena Sammarco, Andrea Elefante, Vittoria Lanni, Domenico Cicala, Francesco Esposito, Ciro Picardi, Adriana Iuliano, Dana Cohen, Giuseppe Mariniello, Antonella D'Aponte, Ciro Costagliola, Francesco Briganti, Diego Strianese
Objective: To assess the effectiveness and safety of oral propranolol for the treatment of ocular adnexal infantile hemangiomas.
Patients and methods: retrospective observational cohort study. Propranolol was administered at an initial oral dose of 1 mg/kg and subsequently increased to 2 mg/kg for 1 year. Outcomes were evaluated by comparing pre- and post-treatment clinical findings, contrast-enhanced ultrasound (CEUS) findings and/or orbital magnetic resonance imaging findings from baseline to 3, 6, 9, 12, 24, and 48 weeks. Regression was graded as follows: satisfactory when 90% and above of the baseline lesion volume and extension decreased, acceptable when 50 to 90%, mediocre when 30 to 50%, poor less than 30%.
Results: Twenty-four patients were included in this study. The mean age at presentation was 4 ± 1 week. Sixteen (71%) patients were females and 7 (29%) were males. The mean follow-up duration was 18 ± 3 months. Therapy was started for of 23/24 patients at 5 weeks old, of 1/24 started at 9 weeks of age. The median age was 5,16 weeks. Sixteen patients (66%) had satisfactory resolution between 3 and 6 weeks, 5 (20%) after 9 weeks, and 3 (12%) after 12 weeks. One patient (5%) had a mediocre response after 24 weeks. One patient withdrew from therapy because of hypoglycemia, which was successfully managed as an outpatient. No significant adverse reactions, such as bradycardia, hypotension, bronchospasm, or congestive heart failure, were detected in this cohort.
Conclusion: This study indicates that the real-life use of oral propranolol for infantile hemangioma yields a high success rate with a lower morbidity than previously reported, particularly when managed by a proficient and multidisciplinary team.
{"title":"Real-life efficacy and safety of oral propranolol for ocular adnexal infantile hemangiomas: observational cohort study.","authors":"Stefano Malvindi, Elena Sammarco, Andrea Elefante, Vittoria Lanni, Domenico Cicala, Francesco Esposito, Ciro Picardi, Adriana Iuliano, Dana Cohen, Giuseppe Mariniello, Antonella D'Aponte, Ciro Costagliola, Francesco Briganti, Diego Strianese","doi":"10.3389/fopht.2025.1493171","DOIUrl":"10.3389/fopht.2025.1493171","url":null,"abstract":"<p><strong>Objective: </strong>To assess the effectiveness and safety of oral propranolol for the treatment of ocular adnexal infantile hemangiomas.</p><p><strong>Patients and methods: </strong>retrospective observational cohort study. Propranolol was administered at an initial oral dose of 1 mg/kg and subsequently increased to 2 mg/kg for 1 year. Outcomes were evaluated by comparing pre- and post-treatment clinical findings, contrast-enhanced ultrasound (CEUS) findings and/or orbital magnetic resonance imaging findings from baseline to 3, 6, 9, 12, 24, and 48 weeks. Regression was graded as follows: satisfactory when 90% and above of the baseline lesion volume and extension decreased, acceptable when 50 to 90%, mediocre when 30 to 50%, poor less than 30%.</p><p><strong>Results: </strong>Twenty-four patients were included in this study. The mean age at presentation was 4 ± 1 week. Sixteen (71%) patients were females and 7 (29%) were males. The mean follow-up duration was 18 ± 3 months. Therapy was started for of 23/24 patients at 5 weeks old, of 1/24 started at 9 weeks of age. The median age was 5,16 weeks. Sixteen patients (66%) had satisfactory resolution between 3 and 6 weeks, 5 (20%) after 9 weeks, and 3 (12%) after 12 weeks. One patient (5%) had a mediocre response after 24 weeks. One patient withdrew from therapy because of hypoglycemia, which was successfully managed as an outpatient. No significant adverse reactions, such as bradycardia, hypotension, bronchospasm, or congestive heart failure, were detected in this cohort.</p><p><strong>Conclusion: </strong>This study indicates that the real-life use of oral propranolol for infantile hemangioma yields a high success rate with a lower morbidity than previously reported, particularly when managed by a proficient and multidisciplinary team.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1493171"},"PeriodicalIF":0.0,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12086078/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144103201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tuberculum sellae meningioma (TSM) is an uncommon tumor among all intracranial meningiomas. As these tumors grow, they compress the surrounding structures, including the optic nerves and the pituitary gland. Ocular motor nerve palsy (OMNP) can occur as an isolated mononeuropathy or as part of multiple cranial nerve palsies. The role of corticosteroids in the management of OMNP has not been fully studied in the literature. In this report, we present a case of a previously well middle-aged woman who presented with severe headache and isolated OMNP on examination. MRI of the brain showed a small TSM that extends into the right optic canal. In our case, we noted the expedient and complete recovery of isolated OMNP within a few days following treatment with dexamethasone. This case report is on an isolated OMNP associated with TSM, which has not been previously reported. In addition, it highlights the role of corticosteroids in achieving rapid recovery from OMNP.
{"title":"Isolated third cranial nerve palsy as the presenting sign of tuberculum sellae meningioma: a case report.","authors":"Azizah Alotaibi, Fay Althunayyan, Shuroq Alshehri, Hosam Al-Jehani","doi":"10.3389/fopht.2025.1525183","DOIUrl":"https://doi.org/10.3389/fopht.2025.1525183","url":null,"abstract":"<p><p>Tuberculum sellae meningioma (TSM) is an uncommon tumor among all intracranial meningiomas. As these tumors grow, they compress the surrounding structures, including the optic nerves and the pituitary gland. Ocular motor nerve palsy (OMNP) can occur as an isolated mononeuropathy or as part of multiple cranial nerve palsies. The role of corticosteroids in the management of OMNP has not been fully studied in the literature. In this report, we present a case of a previously well middle-aged woman who presented with severe headache and isolated OMNP on examination. MRI of the brain showed a small TSM that extends into the right optic canal. In our case, we noted the expedient and complete recovery of isolated OMNP within a few days following treatment with dexamethasone. This case report is on an isolated OMNP associated with TSM, which has not been previously reported. In addition, it highlights the role of corticosteroids in achieving rapid recovery from OMNP.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1525183"},"PeriodicalIF":0.0,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12074959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144082519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}